Superbolan 400 mg is an oil-based injectable blend of Trenbolone Enanthate, Testosterone Enanthate, and Drostanolone Enanthate manufactured by Dragon Pharma and dosed at 400 mg/mL in a 10 mL vial.
Superbolan 400 mg combines three long-acting enanthate esters in a single injectable formulation: trenbolone enanthate (100 mg/mL), testosterone enanthate (200 mg/mL), and drostanolone enanthate (100 mg/mL). This tri-blend is designed for non-medical mass-building and body recomposition applications, where the complementary properties of each compound are commonly referenced together. Testosterone enanthate is an FDA-approved ester for testosterone replacement therapy in adult males with conditions associated with a deficiency or absence of endogenous testosterone . Drostanolone and trenbolone are not approved for human use in the United States.
Each component contributes distinct pharmacological characteristics to the blend. Testosterone enanthate serves as the foundational anabolic hormone, supporting muscle protein synthesis, nitrogen retention, and maintenance of normal male physiological function. Drostanolone enanthate, a DHT-derived compound, does not aromatize and is commonly referenced for its hardening and anti-estrogenic properties. Trenbolone enanthate, a potent 19-nor compound, is known for its pronounced effects on body recomposition, including muscle preservation during caloric deficits. The enanthate ester in all three compounds provides a relatively prolonged release profile, typically requiring injections once or twice per week.
Combining three anabolic steroids in a single injectable introduces compounded cardiovascular and androgenic stress that has not been evaluated in controlled clinical trials. Each component carries its own risk profile. Testosterone can increase blood pressure and hematocrit in controlled clinical trials. Trenbolone has been associated with significant lipid profile alterations and published case reports of severe liver injury. Drostanolone is approximately 5 times as potent as natural methyltestosterone and has been associated with virilization, prostatic hypertrophy, and adverse lipid changes. Non-medical use of Superbolan 400 mg falls outside approved indications and may carry substantial health risks.
Superbolan 400 mg uses MCT oil as its carrier, providing an oil base for the three-enanthate-ester blend. The 400 mg/mL total concentration delivers 100 mg of trenbolone enanthate, 200 mg of testosterone enanthate, and 100 mg of drostanolone enanthate per mL.
Superbolan 400 mg is a tri-ester blend combining three anabolic steroids with distinct pharmacological profiles. Each enanthate ester provides a relatively long duration of action, and the three compounds together address different aspects of physique composition.
The enanthate ester attached to each compound slows release from the injection site, producing a sustained duration of action compared to shorter-acting esters. Testosterone enanthate is an FDA-approved testosterone ester indicated for testosterone replacement therapy in adult males with conditions associated with deficient or absent endogenous testosterone . It serves as the anabolic foundation of the blend, supporting muscle protein synthesis and maintaining normal physiological function. Testosterone aromatizes to estradiol, which can contribute to water retention and estrogenic effects.
Drostanolone enanthate is a DHT-derived compound that does not aromatize to estrogen. It is approximately 5 times as potent as natural methyltestosterone and binds to the androgen receptor, causing downstream genetic transcriptional changes that ultimately cause retention of nitrogen, potassium, and phosphorus; increase protein anabolism; and decrease amino acid catabolism. It is commonly referenced in non-medical contexts for its hardening and anti-estrogenic properties. Drostanolone lacks FDA approval for human use in the United States and has no controlled human safety data at bodybuilding doses.
Trenbolone enanthate is a 19-nor compound with potent anabolic and androgenic activity. It does not aromatize to estrogen, which distinguishes it from testosterone. Trenbolone is used mainly as an anabolic agent in veterinary practice and is not approved for human use. Published case reports have documented severe cholestatic liver injury following trenbolone use in non-medical contexts.
All three compounds in Superbolan 400 mg are esterified with the enanthate chain, providing a relatively prolonged release profile compared to acetate or propionate esters. In non-medical contexts, the blend is commonly referenced as being administered once or twice per week to maintain stable blood levels. The extended release means that side effects, if they occur, may persist for extended periods after discontinuation, and clearance of all three compounds takes several weeks. Forum discussions reference dosages of 1-2 mL per week for a 10-12 week blast.
Dragon Pharma offers individual preparations of each component for users who prefer to control dosing separately. Trenbolone 200 provides trenbolone enanthate as a standalone product, while Masteron 200 provides drostanolone enanthate. Enantat 250 contains testosterone enanthate as a single-compound preparation.
The primary advantage of Superbolan 400 mg is convenience: a single injection delivers all three compounds in a fixed ratio of 1:2:1 (trenbolone:testosterone:drostanolone). However, this fixed ratio means individual dosing adjustments are not possible without additional standalone products. Users who require different ratios of the three compounds may prefer to combine individual preparations. Aromatase inhibitors such as anastrozole are commonly referenced in non-medical contexts when the testosterone component produces estrogenic effects.
The information below is provided for educational reference only. This product contains compounds that are not approved for human use in the United States; non-medical use falls outside any approved indications and carries substantial health risks.
In non-medical bodybuilding contexts, Superbolan 400 mg is commonly referenced in the range of 1–2 mL per week, which delivers 400–800 mg total active compounds per week. This equates to 100–200 mg trenbolone enanthate, 200–400 mg testosterone enanthate, and 100–200 mg drostanolone enanthate per week. Forum discussions reference 1-2 mL per week for a 10-12 week blast, with some users referencing 1.5 mL as a starting point. The 400 mg/mL concentration means that 1 mL provides 400 mg of total active compounds.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Beginner (non-medical) | 1 mL / week | Once weekly |
| Intermediate (non-medical) | 1.5–2 mL / week | Split into two injections |
| Advanced (non-medical) | 2–3 mL / week | Split into two injections |
In non-medical bodybuilding contexts, Superbolan 400 mg is commonly referenced as a standalone mass-building blend, as it already contains three compounds. Adding additional injectable or oral anabolic steroids would compound the total androgenic load and increase cardiovascular and hepatic stress. The fixed ratio may not suit all users, and some may prefer to adjust individual compound ratios using standalone products such as Trenbolone 200, Enantat 250, or Masteron 200.
Cycle lengths of 10–12 weeks are commonly referenced for enanthate-based blends in non-medical contexts. The extended release profile of all three esters means that clearance after the final injection takes several weeks, which must be accounted for when planning post-cycle therapy.
Each component of Superbolan 400 mg carries its own side effect profile. Testosterone enanthate aromatizes to estradiol, which can contribute to water retention, gynecomastia, and elevated blood pressure. Aromatase inhibitors are commonly referenced for managing estrogenic effects.
Drostanolone enanthate, as a DHT derivative, can accelerate hair loss in predisposed individuals and may negatively affect lipid profiles. It has been associated with virilization in women, prostatic hypertrophy, impotence and azoospermia in men, acne, abnormal lipids, and premature cardiovascular disease. A published case report documented severe cholestatic hepatitis in a 19-year-old male who used drostanolone propionate alongside other anabolic steroids.
Trenbolone enanthate is associated with significant cardiovascular effects, including lipid profile alterations, and published case reports have documented severe liver injury. It may also cause insomnia, night sweats, and mood disturbances. The combined androgenic and cardiovascular stress of three compounds used together has not been evaluated in controlled clinical trials.
After completing a cycle with Superbolan 400 mg, post-cycle therapy is commonly recommended in non-medical contexts to help restore endogenous testosterone production. Because all three compounds use the enanthate ester, PCT should begin approximately 2 weeks after the final injection to allow the esters to clear. Agents such as Clomid or Nolvadex are frequently referenced for this purpose. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Superbolan 400 mg contains testosterone enanthate, trenbolone enanthate, and drostanolone enanthate. Only testosterone enanthate is FDA-approved for human use in the United States; trenbolone and drostanolone are not approved for human use. The combination has not been evaluated in controlled clinical trials.
Testosterone enanthate is an FDA-approved androgen indicated for testosterone replacement therapy in adult males with hypogonadism . However, it has not been shown to be safe and effective for athletic performance enhancement, and the FDA label states it should not be used for such purpose. Drostanolone lacks FDA approval for human use and has no controlled human safety data at bodybuilding doses. Trenbolone is used mainly as an anabolic agent in veterinary practice and is not approved for human use. Non-medical use of this combination falls outside any approved indication.
Use of Superbolan 400 mg for bodybuilding or performance enhancement falls outside approved medical indications. The combination of three anabolic steroids introduces compounded cardiovascular, androgenic, and hepatic stress that has not been studied in controlled human trials.
Testosterone enanthate can cause blood pressure increases, which can increase cardiovascular risk over time . In controlled clinical trials, blood pressure increase, gynecomastia, and hematocrit/hemoglobin increase were reported adverse reactions. Edema with or without congestive heart failure may occur in patients with preexisting cardiac, renal, or hepatic disease.
Drostanolone has been associated with virilization in women, prostatic hypertrophy, impotence and azoospermia in men, acne, abnormal lipids, premature cardiovascular disease including stroke and myocardial infarction, abnormal glucose tolerance, and psychiatric disturbances. A published case report documented severe cholestatic hepatitis in a 19-year-old male who used drostanolone propionate alongside other anabolic steroids, with a liver biopsy revealing severe parenchymal and canalicular but predominantly centrolobular cholestasis.
Trenbolone has been associated with significant lipid profile alterations, including decreased HDL and increased LDL. Published case reports have documented severe cholestatic liver injury following trenbolone use. Other reported effects include insomnia, night sweats, and mood disturbances. All three compounds suppress endogenous testosterone production, and the combination may produce more pronounced suppression than any single compound.
Testosterone products are contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, and in women who are pregnant . Trenbolone and drostanolone are not approved for human use and should not be considered appropriate for any medical condition. Individuals with pre-existing cardiovascular disease, hepatic or renal impairment, or hormone-sensitive conditions should exercise particular caution. Existing medical conditions should be discussed with a qualified healthcare professional before any consideration of use.
If Superbolan 400 mg is used in any context, monitoring of blood pressure, hematocrit, lipid profiles, and liver function is important given the known effects of the component compounds. Bloodwork before, during, and after a cycle is commonly referenced as a risk-reduction strategy in non-medical bodybuilding contexts. Laboratory testing of the product itself, such as the published potency report shown in the Lab Reports tab, is separate from clinical monitoring of the person using the medication.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Store at controlled room temperature and protect from light and moisture. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Superbolan 400 mg by Dragon Pharma is shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
To verify your Superbolan 400 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Original Dragon Pharma packaging and batch-linked lab proof help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Superbolan 400 mg, the triple-compound enanthate blend, usage considerations, and product strength.
Superbolan 400 mg contains testosterone enanthate, trenbolone enanthate, and drostanolone enanthate. Testosterone enanthate is FDA-approved for testosterone replacement therapy in adult males with hypogonadism . Trenbolone and drostanolone are not approved for human use. In non-medical bodybuilding settings, Superbolan 400 mg is commonly referenced as a mass-building blend, though such use falls outside approved indications.
Because all three compounds use the enanthate ester, Superbolan 400 mg is typically referenced as being administered once or twice per week in non-medical contexts. The 400 mg/mL concentration means that 1 mL provides 100 mg trenbolone enanthate, 200 mg testosterone enanthate, and 100 mg drostanolone enanthate.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a cycle with Superbolan 400 mg to help restore endogenous testosterone production. All three component compounds suppress natural testosterone production. Because of the enanthate esters, PCT should begin approximately 2 weeks after the final injection. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.
Testosterone enanthate serves as the anabolic foundation, supporting muscle protein synthesis and maintaining normal physiological function. Drostanolone enanthate is a DHT-derived compound that does not aromatize and is commonly referenced for hardening and anti-estrogenic effects. Trenbolone enanthate is a potent 19-nor compound known for pronounced body recomposition effects; it does not aromatize but is associated with significant cardiovascular and hepatic risks.
Because all three compounds use the enanthate ester, Superbolan 400 mg releases gradually over several weeks. In non-medical contexts, users commonly reference noticing effects after approximately 2-4 weeks, with full saturation occurring over 4-6 weeks of use. The extended release means that effects build slowly compared to shorter-acting esters.
There is no single blend that is universally best for mass-building. Superbolan 400 mg combines three compounds with different properties in a fixed ratio. This ratio may not suit all users or goals. Other products such as Trenbolone 200, Enantat 250, or Masteron 200 are also referenced, either alone or in customized combinations.
Cut Long 300 contains drostanolone enanthate, testosterone enanthate, and trenbolone enanthate at 100 mg each (300 mg/mL total). Superbolan 400 mg contains the same three compounds but with a higher testosterone enanthate concentration (200 mg) and a total concentration of 400 mg/mL. Both are long-acting enanthate blends, but Superbolan 400 mg delivers more total active compounds per mL.
A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, Superbolan 400 mg is commonly referenced at 1-2 mL per week, delivering 400-800 mg total active compounds. The combination of three anabolic steroids introduces compounded cardiovascular and androgenic stress that has not been evaluated in controlled trials.
Superbolan 400 mg is labeled at 400 mg of total active compounds per mL, comprising 100 mg trenbolone enanthate, 200 mg testosterone enanthate, and 100 mg drostanolone enanthate per mL. It is supplied in a 10 mL vial, giving 4,000 mg of total labeled content per vial.
Superbolan 400 mg combines three anabolic steroids, each with its own risk profile. Testosterone can increase blood pressure and hematocrit. Drostanolone has been associated with virilization, prostatic hypertrophy, impotence, azoospermia, abnormal lipids, and premature cardiovascular disease. A published case report documented severe cholestatic hepatitis in a user of drostanolone propionate. Trenbolone is used mainly in veterinary practice and is not approved for human use, and has been associated with severe liver injury. The combined cardiovascular and androgenic stress of using three compounds together has not been evaluated in controlled clinical trials.
Yes. Testosterone, trenbolone, and drostanolone are all prohibited substances in sport and can be detected in urine. The enanthate esters have relatively long detection times due to their prolonged release profile. Athletes subject to drug testing should be aware that positive tests can result in sanctions.